Columbus grows EBITDA by 32% in Q1 2025

Columbus delivered a solid start to 2025, driven by improved earnings, confirming the robustness of the company’s strategy and business model. Despite a slight decline in revenue, the company achieved a 32% improvement in EBITDA and significantly strengthened its profitability, increasing the EBITDA margin to 10.7% compared to 7.9% in Q1 2024, adjusted for the extraordinary gain of DKK 20m from the M3CS legal case.

Resilient earnings and continued customer engagement
The macroeconomic environment remains challenging, influenced by geopolitical tensions and shifting investment patterns. While Nordic revenue declined, this was offset by growth especially in the UK market, resulting in a limited revenue decrease of 2%. Strong cost discipline, improved project execution, and a more favorable business mix contributed to the significant EBITDA improvement.

"Delivering 32% EBITDA growth and strengthening our margins in the first quarter of 2025 highlights the resilience and scalability of our business model. In an uncertain global market, we stay committed to our strategic priorities, investing in innovation, talent, and customer partnerships to ensure long-term sustainable growth," says CEO Søren Krogh Knudsen.

Columbus also maintained strong customer activity during the quarter, particularly within the Life Science sector, which showed satisfactory growth. The company further enhanced organizational agility by merging its Customer Experience & Engagement and Dynamics Business Lines into a unified Dynamics 365 unit, improving customer focus and service efficiency.

Progressing with strategic review
We remain focused on day-to-day execution and customer delivery, while carefully evaluating the long-term options that can support our growth ambitions. With a strong balance sheet and solid cash flow generation, we are well positioned to act on strategic opportunities as they arise.

Key figures Q1 2025 (adjusted for extraordinary income in Q1 2024)

• Revenue: DKK 434m (Q1 2024: DKK 444m), corresponding to a decrease of 2%
• EBITDA: DKK 46m (Q1 2024: DKK 35m), corresponding to an increase of 32%
• EBITDA margin: 10.7% (Q1 2024: 7.9%)

Guidance 2025

• Organic revenue growth: 7–9%
• EBITDA-margin: 10–12%

Read the full Interim Report Q1 2025 here: https://ml-eu.globenewswire.com/Resource/Download/28d8b608-d976-4f64-a9dd-a52f0555b418